222 related articles for article (PubMed ID: 24183917)
1. Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence?
Carrat F
Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):9-11. PubMed ID: 24183917
[TBL] [Abstract][Full Text] [Related]
2. Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Goh MJ; Sinn DH
Clin Mol Hepatol; 2022 Jul; 28(3):380-395. PubMed ID: 35021597
[TBL] [Abstract][Full Text] [Related]
3. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
Beales IL; Vardi I; Dearman L; Broughton T
Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
[TBL] [Abstract][Full Text] [Related]
4. Potential for statins in the chemoprevention and management of hepatocellular carcinoma.
Lonardo A; Loria P
J Gastroenterol Hepatol; 2012 Nov; 27(11):1654-64. PubMed ID: 22849701
[TBL] [Abstract][Full Text] [Related]
5. Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials.
Kraglund F; Christensen DH; Eiset AH; Villadsen GE; West J; Jepsen P
Hepatol Commun; 2023 Jan; 7(1):e0013. PubMed ID: 36633465
[TBL] [Abstract][Full Text] [Related]
6. Do aspirin and statins prevent severe sepsis?
Sanchez MA; Thomas CB; O'Neal HR
Curr Opin Infect Dis; 2012 Jun; 25(3):345-50. PubMed ID: 22395760
[TBL] [Abstract][Full Text] [Related]
7. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
Moyad MA; Merrick GS
Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
[TBL] [Abstract][Full Text] [Related]
9. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
El-Serag HB; Johnson ML; Hachem C; Morgana RO
Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
[TBL] [Abstract][Full Text] [Related]
10. Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants.
Wang S; Yu Y; Ryan PM; Dang M; Clark C; Kontogiannis V; Rahmani J; Varkaneh HK; Salehisahlabadi A; Day AS; Zhang Y
Pharmacol Res; 2020 Jan; 151():104585. PubMed ID: 31816436
[TBL] [Abstract][Full Text] [Related]
11. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.
Björkhem-Bergman L; Backheden M; Söderberg Löfdal K
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765
[TBL] [Abstract][Full Text] [Related]
12. Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma.
Simon TG; Chan AT
Clin Liver Dis; 2020 Nov; 24(4):549-576. PubMed ID: 33012445
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms.
Kim G; Kang ES
Semin Liver Dis; 2019 May; 39(2):141-152. PubMed ID: 30912095
[TBL] [Abstract][Full Text] [Related]
14. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.
Girgis RA; McKee HD
Am J Ophthalmol; 2004 Oct; 138(4):697; author reply 697-8. PubMed ID: 15488838
[No Abstract] [Full Text] [Related]
15. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among age-related macular degeneration patients.
Gaynes BI
Am J Ophthalmol; 2004 Dec; 138(6):1089; author reply 1090. PubMed ID: 15629327
[No Abstract] [Full Text] [Related]
16. Chemopreventive strategies in hepatocellular carcinoma.
Singh S; Singh PP; Roberts LR; Sanchez W
Nat Rev Gastroenterol Hepatol; 2014 Jan; 11(1):45-54. PubMed ID: 23938452
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
18. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
[TBL] [Abstract][Full Text] [Related]
19. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
Cunha V; Cotrim HP; Rocha R; Carvalho K; Lins-Kusterer L
Ann Hepatol; 2020; 19(3):232-237. PubMed ID: 31836424
[TBL] [Abstract][Full Text] [Related]
20. The antiinflammatory effects of statins.
McCullough PA
N Engl J Med; 2001 Oct; 345(16):1209; author reply 1210-1. PubMed ID: 11642241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
